Funding Announcement: Angitia Med Secures $120M in Series C round for Revolutionary Rehabilitation Clinic

Angitia Med, a leading rehabilitation clinic renowned for its innovative approach to treating patients with musculoskeletal disorders and pain conditions, has successfully raised an impressive $120 million in funding. This significant investment will bolster the clinic's mission to provide effective pain relief to both adults and children suffering from a diverse range of issues, from chronic pain to post-injury recovery. Angitia's dedicated team of physiotherapists employs cutting-edge manual therapy techniques to work intricately on the fascial and muscular systems, enabling faster recovery times for their patients. With a strong focus on comprehensive anti-edema and anti-cellulite therapy using advanced BTL Shockwave Therapy, coupled with lymphatic drainage, the clinic has achieved outstanding results, particularly for individuals grappling with long-standing pain, swelling, and post-operative adhesions that have previously resisted various rehabilitation methods. The funds raised will be utilized to expand Angitia's facilities and enhance their service offerings, including advanced training for therapists in NDT-Bobath therapy, which is crucial for infants with abnormal muscle tone. This infusion of capital marks a pivotal moment for Angitia Med, propelling their commitment to improving patient outcomes and underscoring their reputation as a frontrunner in the rehabilitation field. The clinic's forward-thinking vision, backed by this substantial funding, promises to touch the lives of many more patients and their families in the journey toward healing and mobility.